BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 2903513)

  • 1. Obsessive-compulsive beliefs and treatment outcome.
    Lelliott PT; Noshirvani HF; Başoğlu M; Marks IM; Monteiro WO
    Psychol Med; 1988 Aug; 18(3):697-702. PubMed ID: 2903513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clomipramine and exposure for obsessive-compulsive rituals: i.
    Marks IM; Stern RS; Mawson D; Cobb J; McDonald R
    Br J Psychiatry; 1980 Jan; 136():1-25. PubMed ID: 6986939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clomipramine treatment of childhood obsessive-compulsive disorder. A double-blind controlled study.
    Flament MF; Rapoport JL; Berg CJ; Sceery W; Kilts C; Mellström B; Linnoila M
    Arch Gen Psychiatry; 1985 Oct; 42(10):977-83. PubMed ID: 3899048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of drug treatment in obsessive-compulsive disorder. A meta-analytic review.
    Piccinelli M; Pini S; Bellantuono C; Wilkinson G
    Br J Psychiatry; 1995 Apr; 166(4):424-43. PubMed ID: 7795913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Return of symptoms after discontinuation of clomipramine in patients with obsessive-compulsive disorder.
    Pato MT; Zohar-Kadouch R; Zohar J; Murphy DL
    Am J Psychiatry; 1988 Dec; 145(12):1521-5. PubMed ID: 3057923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline.
    Insel TR; Murphy DL; Cohen RM; Alterman I; Kilts C; Linnoila M
    Arch Gen Psychiatry; 1983 Jun; 40(6):605-12. PubMed ID: 6342562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared obsessive-compulsive disorder.
    Grover S; Gupta N
    Psychopathology; 2006; 39(2):99-101. PubMed ID: 16424681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obsessive-compulsive disorder.
    Insel TR
    Psychiatr Clin North Am; 1985 Mar; 8(1):105-17. PubMed ID: 3887336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clomipramine and exposure for chronic obsessive-compulsive rituals: III. Two year follow-up and further findings.
    Mawson D; Marks IM; Ramm L
    Br J Psychiatry; 1982 Jan; 140():11-8. PubMed ID: 7037100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clomipramine, self-exposure and therapist-aided exposure for obsessive-compulsive rituals.
    Marks IM; Lelliott P; Basoglu M; Noshirvani H; Monteiro W; Cohen D; Kasvikis Y
    Br J Psychiatry; 1988 Apr; 152():522-34. PubMed ID: 3167404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Six-year follow-up after exposure and clomipramine therapy for obsessive compulsive disorder.
    O'Sullivan G; Noshirvani H; Marks I; Monteiro W; Lelliott P
    J Clin Psychiatry; 1991 Apr; 52(4):150-5. PubMed ID: 2016246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clomipramine and obsessive compulsive disorder: a placebo-controlled double-blind study of 32 patients.
    Greist JH; Jefferson JW; Rosenfeld R; Gutzmann LD; March JS; Barklage NE
    J Clin Psychiatry; 1990 Jul; 51(7):292-7. PubMed ID: 2195006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exposure with response prevention and serotonergic antidepressants in the treatment of obsessive compulsive disorder: a review and implications for interdisciplinary treatment.
    Abel JL
    Behav Res Ther; 1993 Jun; 31(5):463-78. PubMed ID: 8101439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obsessive-compulsive disorder: a double-blind, placebo-controlled trial of clomipramine in 27 patients.
    Jenike MA; Baer L; Summergrad P; Weilburg JB; Holland A; Seymour R
    Am J Psychiatry; 1989 Oct; 146(10):1328-30. PubMed ID: 2675643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
    DeVeaugh-Geiss J; Landau P; Katz R
    Psychopharmacol Bull; 1989; 25(1):36-40. PubMed ID: 2672070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical predictors of treatment response in obsessive compulsive disorder: exploratory analyses from multicenter trials of clomipramine.
    DeVeaugh-Geiss J; Katz R; Landau P; Goodman W; Rasmussen S
    Psychopharmacol Bull; 1990; 26(1):54-9. PubMed ID: 2196627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive versus behavior therapy: processes of change in the treatment of obsessive-compulsive disorder.
    Anholt GE; Kempe P; de Haan E; van Oppen P; Cath DC; Smit JH; van Balkom AJ
    Psychother Psychosom; 2008; 77(1):38-42. PubMed ID: 18087206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clomipramine efficacy for tics, obsessions, and compulsions in Tourette's syndrome and obsessive-compulsive disorder: a case study.
    Ratzoni G; Hermesh H; Brandt N; Lauffer M; Munitz H
    Biol Psychiatry; 1990 Jan; 27(1):95-8. PubMed ID: 2297555
    [No Abstract]   [Full Text] [Related]  

  • 19. Double-blind controlled study in phobias and obsessions.
    Karabanow O
    J Int Med Res; 1977; 5 Suppl 5():42-8. PubMed ID: 340306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-patient treatment for resistant obsessive-compulsive disorder.
    Al-Sughayir MA
    Saudi Med J; 2000 Feb; 21(2):193-5. PubMed ID: 11533781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.